We focus on
Specialty
pharmaceuticals

Global Product Portfolio

SERB benefits from a portfolio of specialty products in Critical Care and Rare Diseases.

SERB has recently strengthened its Neurology and Rare Diseases franchise with the acquisition of Veriton Pharmaceuticals.